Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 3.245
+0.360 (12.48%)
May 25, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 385.25 million as of May 22, 2026. Its market cap has decreased by -12.16% in one year.
Market Cap
385.25M
Enterprise Value
352.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.25
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 385.25M, a decrease of -31.49%. That is a compound annual growth rate of -5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 385.25M | -5.55% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 678.50M |
| Oncopeptides AB | 646.29M |
| Corline Biomedical AB | 475.62M |
| Intervacc AB | 432.83M |
| Mendus AB | 349.07M |
| Sprint Bioscience AB | 345.04M |
| Isofol Medical AB | 230.75M |
| Xintela AB | 223.07M |